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INTRODUCTION:  Angiosarcomas  are  rare  tumours  that  arise  from  the  vascular  endothelium.  They  can
occur  anywhere  in  the  body,  mostly  affecting  the head  and  neck.  Their  occurrence  in  the  gastrointestinal
tract  is  quite  rare  with  a few  reported  cases  in  medical  literature.
PRESENTATION OF  CASE:  A  40-year-old  man  presented  with  metastatic  sigmoid  colon  angiosarcoma,  for
which  he was  operated  due  to  endoscopically  uncontrollable  massive  tumour  bleeding.  The  patient  is
presently  still  alive  at 24  months  after  his  ﬁrst  presentation.  He  is  receiving  palliative  care.
DISCUSSION: This  article  presents  a review  of  the literature  on  this  rare  clinical  entity,  emphasising  theeywords:
ngiosarcoma
olonic angiosarcoma
olorectal cancer
one  metastasis
uscle metastasis
very  aggressive  behaviour  and  the  poor  outcome  of  this  malignancy.  We  present,  brieﬂy,  17 reported
cases  on primary  colonic  angiosarcoma  since  1949.
CONCLUSION: The  role of  chemotherapy  and  radiation  is  established  neither  in  the  adjuvant  setting  nor
in  metastatic  disease.  Surgery  is  the  mainstay  to  treat  localised  colorectal  angiosarcomas.
© 2012 Surgical Associates Ltd. Published by Elsevier Ltd. Open access under CC BY-NC-ND license. 
ower  gastrointestinal bleeding
. Introduction
Gastrointestinal angiosarcomas are very rare malignant
umours that arise from the vascular endothelium, constituting
ar less than 1% of all gastrointestinal tract malignancies and only
% of all sarcomas.1,2 In this article, we present a review of the
iterature on this rare clinical entity, with an emphasis on colorec-
al angiosarcomas, after reporting the case of a 40-year-old male
ho presented to our care with worsening lower gastrointestinal
leeding from a sigmoid colonic angiosarcoma that has shown
o be metastatic to the bone and muscles upon presentation. The
atient underwent a segmental sigmoidectomy to stop rectal
leeding and was referred to the care of the oncologist to receive
hemotherapy, radiation and supportive care. Metastases to the
one and muscles have resulted in severe functional disability.
nterestingly, the patient is still alive at 24 months after his ﬁrst
resentation despite his metastatic disease.
. Report of a case
.1.  HistoryA  40-year-old male presented with a 4-week history of pain-
ess, intermittent rectal bleeding and progressively, worsening pain
nvolving the left hip joint and the right thigh, restricting mildly his
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Open access under CC BY-physical ability. He is an active labourer with no signiﬁcant past his-
tory except for occasional alcohol intake and tobacco smoking. He
denied weight loss or any other constitutional symptoms. Physi-
cal examination revealed no signiﬁcant ﬁndings except for bright,
red blood on rectal examination. Paraclinical studies revealed iron-
deﬁciency anaemia and several areas of translucency involving the
right and left femurs and around the left pelvic girdle. The pelvic
osteolytic lesions were found on abdominal CT that showed no
intra-luminal masses or focal liver lesions. Colonoscopy revealed
an ulcerating, friable polyp at 25 cm from the anal verge with the
presence of blood and clots (Fig. 1). A biopsy showed the mass to
be a glandular epithelioma. CEA and CA19.9 levels were normal.
Among others, HIV test was negative. A bone biopsy was free of
malignancy contradicting the results of a bone scan that consid-
ered the osseous lesions to be highly suggestive of malignancy. The
decision to perform a sigmoid colectomy was  taken because the
patient continued to have severe rectal bleeding that could not be
addressed endoscopically.
2.2.  Pathology
A  sigmoid colectomy was  performed with a smooth early post-
operative course. Macroscopically, the reddish, ulcerating polyp
was 1.5 cm × 1.3 cm × 0.3 cm,  having a sessile morphology. Few
diverticula were noted in the specimen. Histopathology revealed
a malignant, highly vascularised, poorly differentiated tumour
invading the submucosa with a vague aspect (epithelial vs. sar-
comatous). Positive immunohistochemical staining for CD31 and
von Willebrand factor conﬁrmed the endothelial nature of the mass
(Fig. 2), to note; however, that a group of juxtatumoral capillaries
NC-ND license. 
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iFig. 1. A colonoscopic view of the sigmoid tumour.
tained positive for CD34, while tumour cells stained negative for
his marker. Tumour cells stained positive, with variable intensity,
o diverse cytokeratines recognised by the following antibod-
es: CAM 5.2, AE1/AE3 and MNF116. Final pathology revealed an
pitheloid angiosarcoma inﬁltrating both the mucosa and the sub-
ucosa. The specimen had normal margins and was free of any
ymphadenopathy.
.3. Outcome
The early post-operative course was unremarkable. The patient
as referred to the oncologist and was started on a taxane-based
hemotherapy protocol. Three months later and during chemother-
py, the patient presented with abdominal pain that showed to
e secondary to a contained pelvic abscess related to a colonic
erforation that was treated supportively (antibiotics and total
arenteral nutrition) with good resolution and restoration of oral
eeding. Eight weeks later, chemotherapy was resumed. The patient
s presently, at 24 months after his presentation, on supportive care
eing almost continuously bed-ridden secondary to bone and mus-
le metastases that severely restrict his mobility. He is receiving
alliative radiotherapy sessions for his bone metastases.
.  DiscussionAngiosarcomas are a subtype of soft tissue sarcomas and are
ggressive, malignant endothelial-cell tumours of vascular or lym-
hatic origin.4 They account for less than 1% of all soft tissue
ig. 2. A photomicrograph illustrating positive CD31 immunohistochemical stain-
ng in the specimen (×5).PEN  ACCESS
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sarcomas.3 About 60% of these lesions occur in the skin and super-
ﬁcial soft tissues of the head and neck.5 They rarely occur in
the gastrointestinal tract and most of these occur in the stomach
and small bowel.6,7 Colorectal angiosarcomas are rare constituting
less than 0.001% of all colorectal cancers,8 with only a few cases
reported in medical literature (Table 1). The ﬁrst description of a
colonic angiosarcoma was  made by Steiner and Palmer.9
Angiosarcomas have a similar distribution between both sexes.
They can develop at any age, being commoner in older patients.4
The usual presentation of colorectal angiosarcomas is abdom-
inal pain associated with a mass and rectal bleeding. This
context is usually suggestive of colonic adenocarcinoma in spite
of the unusual haemorrhagic endoscopic appearance. Unusual
presentations have also been reported including free intraperi-
toneal bleeding,10,11 intestinal obstruction9,32 and chief complaints
related to metastatic disease.
Most  reported colorectal angiosarcomas have been localised to
the sigmoid colon, which is the case of the patient presented herein.
Several predisposing factors for colorectal angiosarcomas have
been suggested including radiation, chronic lymphoedema and for-
eign body implants11,12 yet no ﬁnal associations can be made.
However, arsenic, thorium dioxide (Thorotrast) and polyvinyl chlo-
ride have been associated with hepatic angiosarcomas.13,14 Most
angiosarcomas arise spontaneously, yet there are few reports
of malignant transformation within pre-existing benign vascular
lesions.4,15
Histopathologically, these tumours are highly vascularised with
abundance of endothelial cells and areas of solid and spindled
cell tumour with an inﬁltrative and destructive growth pattern
typical of angiosarcoma.3 With better immunohistochemical stud-
ies, some atypical sarcomas would now be correctly classiﬁed
as angiosarcomas.10 These tumours typically express endothe-
lial markers including von Willebrand factor, CD34, CD31, Ulex
europaeus agglutinin 1 and vascular endothelial growth fac-
tor (VEGF). Immunohistochemistry is; therefore, a mainstay in
conﬁrming the diagnosis. In poorly differentiated cases, von Wille-
brand factor and CD 31 are the most useful markers. Kaposi’s
sarcoma, which has a similar immunohistochemical staining pat-
tern to conventional angiosarcoma, can be distinguished by its
tendency to be multifocal in the intestine and its usual association
with HIV infection or other forms of immunosuppression.3,16
Tumour size and age at presentation have been suggested
as prognostic factors affecting the course after treatment and
survival in angiosarcomas. Longer survival has been associated
with tumours less than 5 cm;  size has shown to be an indepen-
dent prognostic factor in angiosarcomas.14 Furthermore, younger
age at presentation is associated with better survival, with
patients younger than 50 years of age have a signiﬁcantly bet-
ter 2-year survival rate compared to older patients.3,13 However,
data regarding better survival in younger patients is sometimes
conﬂicting.17,21,30 Other obvious factors associated with a poorer
outcome include metastatic disease at presentation, poor patient
performance status4,18 and involved margins (R1 or R2) upon
resection.
Concerning tumour staging, the International Union Against
Cancer and the American Joint Committee on Cancer (UICC/AJCC)
staging systems apply. This is based on the TNM (tumour-
node-metastasis) staging system with an additional notation for
histological grade.19 By deﬁnition, angiosarcomas are high-grade
tumours. The tumour size deﬁnes the T entity in the TNM system,
with tumours less than or equal to 5 cm being T1, larger tumours
being T2.
As  for treatment, radical surgery with complete (R0) resection is
the treatment of choice. Wide margins are recommended because
of the invasive and often multifocal nature of angiosarcoma,4 but
this is often difﬁcult to achieve. The role of adjuvant therapy in
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Table 1
A  summary of 17 reported cases on primary colonic and rectal angiosarcoma since 1949.
Author Patient Age,
Gender
Tumour size (max.
diameter  in cm.)
Tumour location Clinical presentation Treatment Outcome
Steiner and Palmer9 46, Female 3.5 Sigmoid Abdominal pain,
palpable  mass and
obstruction
Sigmoidectomy  Alive 21 months
postoperatively with uterine
recurrence
Ormos  and Sin22 34, Female 7 Cecum Abdominal pain,
palpable  mass, weight
loss
Right  hemicolectomy
with  adjuvant
radiotherapy
Died  23 months
postoperatively with liver
metastases
Saito  et al.23 72, Male 10 Descending colon Abdominal pain, rectal
bleeding
Left  colectomy Death from disseminated
disease  1 month
postoperatively
Taxy  and Battifora24 57, Female 6 Cecum N/A Right hemicolectomy Death from disseminated
disease  6 months
postoperatively
Lo  et al.25 37, Male 2 Rectum Rectal  bleeding Abdomino-perineal
resection
Alive 18 months
postoperatively with no
recurrence
Smith  et al.26 16, Female 5.5 Sigmoid Abdominal pain,
palpable  mass, rectal
bleeding
Sigmoidectomy  Alive and disease-free 36
months postoperatively
Deleaval  et al.27 74, Female 3 Cecum, transverse
colon  and rectum
Melaena  Palliative care Died at about 1 month after
diagnosis
Hofman  et al.28 66, Male 6 Sigmoid Abdominal pain, rectal
bleeding
Sigmoidectomy  Death from disseminated
disease  5 months
postoperatively
Solheim  et al.29 75, Female NA Cecum Systemic upset, weight
loss
Right  hemicolectomy Death from disseminated
disease  4 months
postoperatively
Ben-Izhak  et al.12 70, Female 5 Rectum Rectal bleeding Surgical resection and
adjuvant radiotherapy
Death  from persistent
haemorrhage 2 months
postoperatively
Watanabe  et al.30 70, Female 1.7 Sigmoid Rectal bleeding Sigmoidectomy Alive at 2 years follow-up
Rozario and Ravi31 55, Male 2.5 Cecum Abdominal pain,
palpable  abdominal
mass
Right  hemicolectomy Alive 13 months
postoperatively with no
recurrence
Brown  et al.3 77, Male 4.5 Sigmoid Rectal bleeding,
abdominal mass,
weight  loss
Sigmoid colectomy Died 6 months postoperatively
with  liver metastases
Komorowski  et al.32 17, Male 12 Sigmoid Rectal bleeding,
constipation
Sigmoid  colectomy Alive and well 19 months
postoperatively
El  Chaar and
McQuary11
60, Female N/A Sigmoid Abdominal pain Segmental resection Died 4 months postoperatively
with  metastases
Pascual  et al.21 85, Female 2 Cecum Lower  gastrointestinal
bleeding,
haemorrhagic shock
Right hemicolectomy Alive 24 months
postoperatively with no
evidence  of recurrence
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ngiosarcoma is unclear, but there generally seems to be limited, if
ny, survival beneﬁt with adjuvant chemotherapy in the treatment
f sarcomas.3,13 Limited experience in angiosarcomas has shown
isappointing results.13
Cytotoxic chemotherapy is the primary treatment option for
etastatic angiosarcoma, although the evidence for this is also
imited. Anthracyclines, ifosfamide and more recently taxanes are
he mainstay of chemotherapy.4 Furthermore, biological therapies,
n particular antiangiogenic therapies, may  have a signiﬁcant role
n the treatment of angiosarcomas, either in the adjuvant setting or
s a primary option in metastatic disease.20
. Conclusion
Angiosarcoma of the colon and rectum is a rare malignancy.
he case presented in this article and the review of literature sug-
est that colorectal angiosarcomas behave aggressively resulting in
oor outcomes. No clear-cut guidelines concerning prognostic fac-
ors and treatment options can be made. However, complete (R0)
urgical resection is the only treatment that has shown to result
n long-term survival. Younger age at presentation and tumours
ess than 5 cm may  be associated with better outcomes, yet thedominal pain and
raperitoneal
eding
Sigmoid  colectomy Alive 36 months
postoperatively with no
evidence  of recurrence
overall  survival is generally poor. The role of adjuvant therapy
and chemotherapy/radiation in the context of metastatic disease is
unclear reﬂecting the need for further prospective studies to clarify
treatment strategies.
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